Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination

N/ACompletedNCT02003508

The Alfred345 enrolled

Overview

This study will examine how common HPV infection is in teenage males in Australia before and after the introduction of universal school based vaccination of males in Australia.

Males aged 17 to 19 in Australia will be recruited from 2014. Men will undergo sampling from the penis for HPV. The prevalence of HPV infection will be determined in 2014-2015 and compared to the prevalence in 2016-2017.

Study Type

OBSERVATIONAL

Enrollment

345

Conditions

Human Papillomavirus

Eligibility

Sex: MALEMin age: 17 YearsMax age: 19 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Male * Aged 17 to 19 * Able to complete study requirements * Residing in Australia from 12 years of age Exclusion Criteria: -Males reporting sex with males in the past 12 months

Locations (1)

Melbourne Sexual Health Centre

Melbourne, Victoria, Australia

Outcomes

Primary Outcomes

Prevalence of Penile HPV Genotypes

Prevalence of penile HPV genotypes among heterosexually active young men. Percentage of participants with specific genotypes on penile samples, as detected by Linear Array. Participants provided a single penile sample.

Time frame: Single study visit (one time point per participant)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.